Enthera Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $42.6M
Latest Deal Amount
  • Investors
  • 7

Enthera General Information

Description

Developer of biotherapeutics intended to treat auto-immune disorders. The company's pipelined products target pathways involved in cell apoptosis in the gut, pancreas and other organs which plays a key role in the development of type 1 diabetes and inflammatory bowel disease, enabling the medical community to effectively combat intractable autoimmune diseases.

Contact Information

Website
www.entherapharmaceuticals.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Via Gioberti, 8
  • 20123 Milan
  • Italy
+39 02 0000 0000

Enthera Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enthera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 28-Jan-2021 $42.6M 000.00 Completed Clinical Trials - General
3. Early Stage VC 01-Jan-2020 00.000 Completed Clinical Trials - General
2. Seed Round 24-Jul-2018 $4.67M $4.67M Completed Clinical Trials - General
1. Seed Round 01-Oct-2016 Completed Clinical Trials - General
To view Enthera’s complete valuation and funding history, request access »

Enthera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biotherapeutics intended to treat auto-immune disorders. The company's pipelined products target pathways i
Drug Discovery
Milan, Italy
7 As of 2021
000.00
00000000000 000.00

0000000

ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000 0

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000000000000
South San Francisco, CA
0 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enthera Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViaCyte Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed South San Francisco, CA 0 00000 000000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Newton, MA 00 00000 000000000 00000
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
You’re viewing 5 of 34 competitors. Get the full list »

Enthera Executive Team (6)

Name Title Board Seat Contact Info
Giovanni Amabile Ph.D Chief Executive Officer & Board Member
Paolo Fiorina MD Chief Scientific Officer & Co-Founder
Lucia Reggi Financial Director
Francesca D'Addio Ph.D Co-Founder & Head of Preclinical Research
Silvano Spinelli Co-Founder and Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Enthera Board Members (9)

Name Representing Role Since
Anta Gkelou Ph.D Sofinnova Partners Board Member 000 0000
Carole Nuechterlein JD Roche Venture Fund Board Member 000 0000
Giovanni Amabile Ph.D Enthera Chief Executive Officer & Board Member 000 0000
Graziano Seghezzi Sofinnova Partners Board Member 000 0000
Katie Elias Enthera Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Enthera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enthera Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Roche Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Indaco Venture Partners Venture Capital Minority 000 0000 000000 0
Juvenile Diabetes Research Foundation Limited Partner Minority 000 0000 000000 0
Sofinnova Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial